# Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting

> **NCT02617290** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1900 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Ischemia
- Myocardial Infarction
- Stent Thrombosis
- Cardiovascular Diseases

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02617290
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-09
- **Primary completion:** 2020-05-29
- **Final completion:** 2020-09-15
- **Target enrollment:** 1900 (ACTUAL)
- **Last updated:** 2020-10-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02617290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02617290, "Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02617290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*